Compare CDNA & MEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CDNA | MEG |
|---|---|---|
| Founded | 1998 | 2012 |
| Country | United States | United States |
| Employees | N/A | 3500 |
| Industry | Medical Specialities | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 930.8M |
| IPO Year | 2007 | 2020 |
| Metric | CDNA | MEG |
|---|---|---|
| Price | $18.20 | $22.83 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 4 |
| Target Price | $27.33 | ★ $35.25 |
| AVG Volume (30 Days) | ★ 497.3K | 294.0K |
| Earning Date | 04-29-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 93.69 |
| EPS | N/A | ★ N/A |
| Revenue | $48,324,000.00 | ★ $830,538,000.00 |
| Revenue This Year | $16.01 | $5.46 |
| Revenue Next Year | $11.31 | $7.10 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 18.93 | ★ 19.26 |
| 52 Week Low | $10.96 | $10.51 |
| 52 Week High | $21.49 | $32.00 |
| Indicator | CDNA | MEG |
|---|---|---|
| Relative Strength Index (RSI) | 53.83 | 46.35 |
| Support Level | $18.30 | $21.11 |
| Resistance Level | $19.14 | $23.78 |
| Average True Range (ATR) | 0.79 | 1.07 |
| MACD | 0.14 | -0.10 |
| Stochastic Oscillator | 76.38 | 41.37 |
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
Montrose Environmental Group Inc is an environmental services company. The firm's operating segments are Assessment, Permitting and Response, Measurement and Analysis, and Remediation and Reuse. Through its Assessment, Permitting, and Response segment, the company provides scientific advisory and consulting services to support environmental assessments, environmental emergency response, and environmental audits and permits. Measurement and Analysis include test and analysis of air, water, and soil to determine concentrations of contaminants whereas, the Remediation and Reuse segment provide clients with engineering, design, implementation, operations and maintenance services, to treat contaminated water, and soil remediation. The company derives maximum revenue from United States.